The present invention provides a compound of formula I: ##STR00001## or a pharmaceutically acceptable derivative thereof. These compounds are inhibitors of protein kinases, particularly inhibitors of GSK3 mammalian protein kinase. The invention also provides pharmaceutically acceptable compositions comprising the compounds of the invention and methods of utilizing those compounds and compositions in the treatment of various protein kinase mediated disorders.

 
Web www.patentalert.com

< Antimycobacterial pharmaceutical composition

> Chemokine receptor binding compounds

~ 00499